Stable improvement in classical B-cell chronic lymphocytic leukemia with dietary interventions: A personal experience - PubMed (original) (raw)
Case Reports
. 2020 Sep 14;8(12):2948-2954.
doi: 10.1002/ccr3.3305. eCollection 2020 Dec.
Affiliations
- PMID: 33363857
- PMCID: PMC7752481
- DOI: 10.1002/ccr3.3305
Case Reports
Stable improvement in classical B-cell chronic lymphocytic leukemia with dietary interventions: A personal experience
Frans X Plooij et al. Clin Case Rep. 2020.
Abstract
If the lymphocyte count is still low enough, the first part of the wait-and-see approach for asymptomatic Rai stage 0 classical B-CLL can be used to find out if the lymphocyte counts follow an exponential growth curve. If they do, the whole food, plant-based (WFPB) diet intervention can be started.
Keywords: B‐CLL; dietary intervention; hematology; lifestyle medicine; oncology; plant‐based diet; whole food.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
Figures
Figure 1
Course of disease related to three dietary interventions. The remarkably consistent and stable reversal of the progressive CLL co‐occurring with a sharp decrease in body weight (gray line) after starting the Flexitarian diet (yellow box) followed by the Whole Food Plant‐Based (WFPB) diet intervention (blue box). Initially, the leukocytes (blue dots) follow an exponential growth curve that is depicted by the black, broken line fitted through the first 5 measurements and extrapolated; y = 13.401e0,0057 x; R 2 = .9919). (Note: In week 0, no lymphocyte count was available in the hospital records. Therefore, the leukocyte counts were used for fitting and extrapolating the exponential growth curve. This is considered a good proxi since the lymphocyte counts tend to follow the leukocyte counts, albeit a little lower). The epigallocatechin gallate (EGCG) therapy (pink box) had no effect whatsoever: the leukocyte (blue dots) and lymphocyte (red dots) counts did not deviate from the extrapolated curve. After the reversal of the progressive CLL, the lymphocyte counts (red dots) stabilized around a mean of 41 × 109/L (SD = 5). A linear trend with a slightly downward slope (see the red, dotted line; y = −0.0118_x_ + 46.623; R 2 = .0293) was fitted through the lymphocyte counts following the reversal. The body weight curve (gray line) depicts a moving average of onethird of the measurement points
Similar articles
- Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA. Shanafelt TD, et al. J Clin Oncol. 2009 Aug 20;27(24):3959-63. doi: 10.1200/JCO.2008.21.2704. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620484 Free PMC article. - Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, Liso V, Cuneo A, Foà R. Molica S, et al. Haematologica. 2011 Feb;96(2):277-83. doi: 10.3324/haematol.2010.030189. Epub 2010 Oct 22. Haematologica. 2011. PMID: 20971821 Free PMC article. - Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia.
Michelis R, Milhem L, Galouk E, Stemer G, Aviv A, Tadmor T, Shehadeh M, Shvidel L, Barhoum M, Braester A. Michelis R, et al. Front Immunol. 2022 Sep 2;13:953644. doi: 10.3389/fimmu.2022.953644. eCollection 2022. Front Immunol. 2022. PMID: 36119042 Free PMC article. - Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
Strati P, Shanafelt TD. Strati P, et al. Blood. 2015 Jul 23;126(4):454-62. doi: 10.1182/blood-2015-02-585059. Epub 2015 Jun 11. Blood. 2015. PMID: 26065657 Free PMC article. Review. - Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S, De Rossi G, Luciani M, Levato D. Molica S, et al. Haematologica. 1995 Mar-Apr;80(2):176-93. Haematologica. 1995. PMID: 7628755 Review.
Cited by
- The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial.
Rojas Gil AP, Kodonis I, Ioannidis A, Nomikos T, Dimopoulos I, Kosmidis G, Katsa ME, Melliou E, Magiatis P. Rojas Gil AP, et al. Front Oncol. 2022 Jan 21;11:810249. doi: 10.3389/fonc.2021.810249. eCollection 2021. Front Oncol. 2022. PMID: 35127522 Free PMC article.
References
- Campbell TC. The past, present, and future of nutrition and cancer: part 1‐was a nutritional association acknowledged a century ago? Nutr Cancer. 2017;69(5):811‐817. - PubMed
- Campbell TC. Nutrition and cancer: an historical perspective.‐the past, present, and future of nutrition and cancer. Part 2. Misunderstanding and ignoring nutrition. Nutr Cancer. 2017;69(6):962‐968. - PubMed
- Chen J, Campbell TC, Li J, et al. Diet, life‐style and mortality in China. A study of the characteristics of 65 Chinese counties. Oxford, England: Oxford University Press; 1990.
Publication types
LinkOut - more resources
Full Text Sources